X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1922) 1922
Book Review (237) 237
Publication (203) 203
Book Chapter (14) 14
Conference Proceeding (9) 9
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1834) 1834
humans (1761) 1761
ophthalmology (1515) 1515
male (1296) 1296
female (1281) 1281
aged (1111) 1111
middle aged (951) 951
macular degeneration (933) 933
choroidal neovascularization - physiopathology (910) 910
fluorescein angiography (767) 767
visual acuity - physiology (758) 758
choroidal neovascularization (731) 731
aged, 80 and over (717) 717
choroidal neovascularization - drug therapy (617) 617
macular degeneration - physiopathology (604) 604
tomography, optical coherence (602) 602
treatment outcome (585) 585
photodynamic therapy (546) 546
retrospective studies (495) 495
ranibizumab (488) 488
follow-up studies (478) 478
vascular endothelial growth factor a - antagonists & inhibitors (476) 476
bevacizumab (462) 462
choroidal neovascularization - etiology (454) 454
visual acuity (441) 441
intravitreal injections (439) 439
angiogenesis inhibitors - therapeutic use (429) 429
adult (409) 409
age-related macular degeneration (397) 397
verteporfin (379) 379
prospective studies (356) 356
neovascularization (335) 335
photochemotherapy (318) 318
macular degeneration - complications (310) 310
macular degeneration - drug therapy (309) 309
angiogenesis inhibitors - administration & dosage (297) 297
antibodies, monoclonal, humanized (281) 281
animals (276) 276
endothelial growth-factor (276) 276
choroidal neovascularization - diagnosis (272) 272
eye diseases (272) 272
optical coherence tomography (249) 249
physiological aspects (240) 240
vascular endothelial growth factor (240) 240
wet macular degeneration - physiopathology (227) 227
care and treatment (211) 211
choroid - blood supply (205) 205
injections (202) 202
abridged index medicus (198) 198
vitreous body (192) 192
photosensitizing agents - therapeutic use (191) 191
porphyrins - therapeutic use (189) 189
wet macular degeneration - drug therapy (188) 188
subfoveal choroidal neovascularization (187) 187
retina (183) 183
antibodies, monoclonal - administration & dosage (179) 179
age (178) 178
diabetic retinopathy (171) 171
genetic structures (170) 170
sense organs (170) 170
medical imaging (167) 167
medicine & public health (162) 162
fundus oculi (160) 160
retina - pathology (158) 158
antibodies, monoclonal, humanized - therapeutic use (155) 155
indocyanine green (153) 153
visual acuity - drug effects (151) 151
analysis (144) 144
research (138) 138
angiogenesis (133) 133
antibodies, monoclonal - therapeutic use (133) 133
mice (132) 132
time factors (131) 131
degeneration (129) 129
injection (126) 126
avastin (123) 123
secondary (123) 123
retreatment (121) 121
intravitreal bevacizumab (120) 120
retina - physiopathology (120) 120
eye (119) 119
polypoidal choroidal vasculopathy (117) 117
antibodies, monoclonal, humanized - administration & dosage (116) 116
maculopathy (116) 116
risk factors (114) 114
myopia (113) 113
therapy (113) 113
randomized clinical-trial (112) 112
coloring agents (110) 110
eyes (110) 110
prognosis (109) 109
choroidal neovascularization - pathology (108) 108
macular degeneration - diagnosis (108) 108
studies (108) 108
wet macular degeneration - diagnosis (108) 108
disease models, animal (106) 106
pathological myopia (106) 106
prevalence (105) 105
myopia, degenerative - physiopathology (104) 104
patients (104) 104
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1861) 1861
German (15) 15
Russian (12) 12
French (11) 11
Czech (6) 6
Japanese (6) 6
Romanian (4) 4
Polish (3) 3
Portuguese (2) 2
Chinese (1) 1
Hungarian (1) 1
Serbian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 09/2016, Volume 36, Issue 9, pp. 1919 - 1927
OBJECTIVE—Pathological ocular neovascularization is a major cause of blindness. Increased dietary intake of ω-3 long-chain polyunsaturated fatty acids (LCPUFA)... 
Diabetic retinopathy | Choroidal neovascularization | Arachidonic acid | Docosahexaenoic acid | CYP2C inhibitor | Neovascularization, Physiologic - drug effects | Humans | Retinopathy of Prematurity - genetics | Quinolines - pharmacology | Retinopathy of Prematurity - physiopathology | Fatty Acids, Omega-3 - pharmacology | Lasers | Hyperoxia - complications | Retinopathy of Prematurity - enzymology | Retinal Neovascularization - enzymology | Retinal Neovascularization - prevention & control | Retinal Neovascularization - genetics | Cytochrome P-450 CYP2C8 - metabolism | Aorta - enzymology | Disease Models, Animal | Cytochrome P-450 CYP2C8 Inhibitors - pharmacology | Fatty Acids, Omega-3 - metabolism | Tissue Culture Techniques | Aorta - drug effects | Mice, Inbred C57BL | Cells, Cultured | Choroidal Neovascularization - enzymology | Angiogenesis Inhibitors - pharmacology | Genotype | Mice, Transgenic | Choroidal Neovascularization - prevention & control | Choroidal Neovascularization - physiopathology | Phenotype | Animals | Retinopathy of Prematurity - prevention & control | Acetates - pharmacology | Cytochrome P-450 CYP2C8 - genetics | Retinal Neovascularization - physiopathology | Choroidal Neovascularization - genetics | Endothelial Cells - enzymology | Endothelial Cells - drug effects | Index Medicus | pathological angiogenesis | ω-3 LCPUFA
Journal Article
Ophthalmology, ISSN 0161-6420, 2006, Volume 113, Issue 3, pp. 363 - 372.e5
To report the short-term safety, biologic effect, and a possible mechanism of action of intravitreal bevacizumab in patients with neovascular age-related... 
VERTEPORFIN | TISSUE-PLASMINOGEN ACTIVATOR | PHOTODYNAMIC THERAPY | PHARMACOKINETICS | FACTOR ANTIBODY FRAGMENT | INJECTION | COHERENCE TOMOGRAPHY FINDINGS | DISEASE | OPHTHALMOLOGY | ENDOTHELIAL GROWTH-FACTOR | SUBFOVEAL CHOROIDAL NEOVASCULARIZATION | Retina - drug effects | Choroidal Neovascularization - diagnosis | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Choroidal Neovascularization - etiology | Male | Retinal Detachment - drug therapy | Macular Degeneration - diagnosis | Macular Degeneration - drug therapy | Bevacizumab | Antibodies, Monoclonal, Humanized | Choroidal Neovascularization - drug therapy | Retinal Detachment - diagnosis | Aged, 80 and over | Vitreous Body | Female | Retrospective Studies | Antibodies, Monoclonal - immunology | Fluorescein Angiography | Macular Degeneration - physiopathology | Tomography, Optical Coherence | Fovea Centralis | Macular Degeneration - complications | Vascular Endothelial Growth Factor A - immunology | Visual Acuity | Choroidal Neovascularization - physiopathology | Pigment Epithelium of Eye | Injections | Antibodies, Monoclonal - administration & dosage | Papilledema - diagnosis | Aged | Retina - pathology | Papilledema - drug therapy | Macular degeneration | Physiological aspects | Eye diseases | Angiogenesis inhibitors | Index Medicus
Journal Article
Journal Article